Why buy them out when ICL can wait patiently as the price gets cheaper each quarter?
If and when management turn it around then we might see some interest.
Still can't shake the feeling that the signed deals with ICL are just to string Alexium along, there's just never any $ behind it.
Ann: Appendix 4C - quarterly, page-10
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
